Oxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885

Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease

Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

Selhub, J., Jacques, P. F., Bostom, A. G., D’Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O’Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,213

Review on in vivo and in vitro methods evaluation of antioxidant activity

Alam, M. N., Bristi, N. J., & Rafiquzzaman, M. (2012) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.05.002 · Cited by 1,868

Involvement of oxidative stress in Alzheimer disease

Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611

Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564

Amyloid β -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526

Indian medicinal herbs as sources of antioxidants

Ali, S. S., Kasoju, N., Luthra, A., Singh, A., Hallihosur, S., Sahu, A., & Bora, U. (2007) · Food Research International · doi:10.1016/j.foodres.2007.10.001 · Cited by 468

In vitro models for antioxidant activity evaluation and some medicinal plants possessing antioxidant properties: An overview

Ch, S., & Dave, R. A. (2009) · African Journal of Microbiology Research · doi:10.5897/ajmr.9000401 · Cited by 406

Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease

Mandal, P. K., Saharan, S., Tripathi, M., & Murari, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.005 · Cited by 344

Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis

Schrag, M., Mueller, C., Zabel, M. K., Crofton, A. R., Kirsch, W. M., Ghribi, O., Squitti, R., & Perry, G. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.005 · Cited by 342

Role of Oxidative Stress in the Progression of Alzheimer's Disease

Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1222 · Cited by 336

Antioxidant Capacity Determination in Plants and Plant‐Derived Products: A Review

Pisoschi, A. M., Pop, A., Cimpeanu, C. L., & Predoi, G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9130976 · Cited by 329

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289

Cognitive enhancement and neuroprotective effects of Bacopa monnieri in alzheimer’s disease model

Uabundit, N., Wattanathorn, J., Mucimapura, S., & Ingkaninan, K. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.056 · Cited by 282

Recent advances in our understanding of neurodegeneration

Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274

Mild Cognitive Impairment: A Systematic Review

Mariani, E., Monastero, R., & Mecocci, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12104 · Cited by 248

Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death

Wang, X., Hu, X., Yang, Y., Takata, T., & Sakurai, T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.060 · Cited by 217

The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?

Smith, A. D. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s119 · Cited by 221

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215

Diet, cognition, and alzheimer’s disease: food for thought

Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martínez-Lage, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0561-3 · Cited by 214

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease

Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209

Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias

Casado, Á., López-Fernández, M. E., Casado, M. C., & de la Torre, R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9453-3 · Cited by 209

Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects

Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243

Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies

Tinelli, C., Pino, A. D., Ficulle, E., Marcelli, S., & Feligioni, M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00049 · Cited by 203

Mitochondrial Dysfunction: The First Domino in Brain Aging and Alzheimer's Disease?

Leuner, K., Hauptmann, S., Abdel-Kader, R. M., Scherping, I., Keil, U., Strosznajder, J. B., Eckert, A., & Müller, W. E. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1763 · Cited by 195

Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms

Rommy von Bernhardi, M., & Eugenín, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 193

Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H., Zhu, X., Smith, M. A., & Perry, G. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9331-x · Cited by 185

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179

Mitochondrial DNA Oxidative Damage and Repair in Aging and Alzheimer's Disease

Santos, R. X., Correia, S. C., Zhu, X., Smith, M. A., Moreira, P. I., Castellani, R. J., Nunomura, A., & Perry, G. L. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5039 · Cited by 182

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism

Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 182

The emerging role of glutathione in Alzheimer’s disease

Saharan, S., & Mandal, P. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132483 · Cited by 168

RNA oxidation in Alzheimer disease and related neurodegenerative disorders

Nunomura, A., Hofer, T., Moreira, P. I., Castellani, R. J., Smith, M. A., & Perry, G. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0508-1 · Cited by 148

The Roles of Biomarkers of Oxidative Stress and Antioxidant in Alzheimer’s Disease: A Systematic Review

Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 145

Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease

Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 140

Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors

Guglielmotto, M. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2010 · Cited by 135

Oxidative Stress in Alzheimer's Disease and Mild Cognitive Impairment with High Sensitivity and Specificity

López, N., Tormo, C., Blas, I. D., Llinares, I., & Alom, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121528 · Cited by 135

A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress–mediated mitochondrial injury

Sompol, P. M., Ittarat, W., Tangpong, J., Chen, Y., Doubinskaia, I. E., Batinic-Haberle, I., Abdul, H. M., Butterfield, D. A., & Clair, D. K. S. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.044 · Cited by 137

Oxidative Damage to RNA in Neurodegenerative Diseases

Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M. A., & Perry, G. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/82323 · Cited by 133

Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder

Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 126

Biomarkers in Alzheimer's disease drug development

Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 122

Oxidative modification of lipoic acid by HNE in Alzheimer disease brain

Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120

One-Carbon Metabolism and Alzheimers Disease: Focus on Epigenetics

Coppedè, F. (2010) · Current Genomics · doi:10.2174/138920210791233090 · Cited by 118

Amyloid-β Production: Major Link Between Oxidative Stress and BACE1

Tamagno, E., Guglielmotto, M., Monteleone, D., & Tabaton, M. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9283-6 · Cited by 117

The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

Skvarc, D., Dean, O. M., Byrne, L. K., Gray, L. J., Lane, S. E., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.013 · Cited by 111

Dietary diversity and cognitive function among elderly people: A population-based study

Yin, Z. X., Fei, Z., Qiu, C., Brasher, M. S., Kraus, V. B., Zhao, W., Shi, X., & Zeng, Y. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0912-5 · Cited by 110

The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats

Chepulis, L. M., Starkey, N. J., Waas, J. R., & Molan, P. C. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.03.001 · Cited by 112

Environmental and dietary risk factors in Alzheimer’s disease

Dosunmu, R., Wu, J., Basha, R. M., & Zawia, N. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.887 · Cited by 114

Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model

Chu, Y.-F., Chang, W.-H., Black, R. M., Liu, J.-R., Sompol, P., Chen, Y., Wei, H., Zhao, Q., & Cheng, I. H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.04.148 · Cited by 106

Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2

Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 109

Recent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems

Cacciatore, I., Baldassarre, L., Fornasari, E., Mollica, A., & Pinnen, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/240146 · Cited by 106

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia

Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Passaro, A., Bergamini, C. M., Pilotto, A., & Zuliani, G. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.041 · Cited by 101

Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin

Tchekalarova, J. D., & Tzoneva, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033022 · Cited by 105

Anti-inflammatory and antioxidant nanostructured cellulose membranes loaded with phenolic-based ionic liquids for cutaneous application

Morais, E. S., Silva, N. H. C. S., Sintra, T. E., Santos, S. A. O., Neves, B. M., Almeida, I. F., Costa, P. C., Correia‐Sá, I., Ventura, S. P. M., Silvestre, A. J. D., et al. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.10.051 · Cited by 93

Blood markers of oxidative stress in A lzheimer's disease

Skoumalová, A., & Hort, J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01585.x · Cited by 93

Silibinin Attenuates Amyloid β25–35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor-α in Mice

Lü, P., Mamiya, T., Lu, L., Mouri, A., Niwa, M., Hiramatsu, M., Zou, L., Nagai, T., Ikejima, T., & Nabeshima, T. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155069 · Cited by 80

Fatty Acids, Antioxidants and Physical Activity in Brain Aging

Freitas, H. R., Ferreira, G. C., Trevenzoli, I. H., Oliveira, K. J., & Reis, R. A. D. M. (2017) · Nutrients · doi:10.3390/nu9111263 · Cited by 85

Assessment of effect of hydroalcoholic and decoction methods on extraction of antioxidants from selected Indian medicinal plants

Kaneria, M., Kanani, B., & Chanda, S. V. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60041-0 · Cited by 86

Association between Helicobacter pylori infection and mild cognitive impairment

Kountouras, J., Tsolaki, M., Boziki, M. K., Gavalas, E., Zavos, C., Stergiopoulos, C., Kapetanakis, N., Chatzopoulos, D., & Venizelos, I. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01827.x · Cited by 80

Oxidative stress and antioxidant defenses in mild cognitive impairment: A systematic review and meta-analysis

Nantachai, G., Vasupanrajit, A., Tunvirachaisakul, C., Solmi, M., & Maes, M. H. J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101639 · Cited by 72

Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer's Disease

Cervellati, C., Cremonini, E., Bosi, C., Magon, S., Zurlo, A., Bergamini, C. M., & Zuliani, G. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040003 · Cited by 70

Use of medical foods and nutritional approaches in the treatment of Alzheimer’s disease

Thaipisuttikul, P., & Galvin, J. E. (2012) · Clinical Practice · doi:10.2217/cpr.12.3 · Cited by 70

Bioinspired Near-Infrared-Excited Sensing Platform for in Vitro Antioxidant Capacity Assay Based on Upconversion Nanoparticles and a Dopamine–Melanin Hybrid System

Wang, D., Chen, C., Ke, X., Kang, N., Shen, Y., Liu, Y., Zhou, X., Wang, H., Chen, C., & Ren, L. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am5086269 · Cited by 69

Quantitation of in vivo brain glutathione conformers in cingulate cortex among age‐matched control, MCI, and AD patients using MEGA‐PRESS

Shukla, D., Mandal, P. K., Tripathi, M., Vishwakarma, G., Mishra, R., & Sandal, K. (2019) · Human Brain Mapping · doi:10.1002/hbm.24799 · Cited by 70

Effects of Exercise on Inflammatory, Oxidative, and Neurotrophic Biomarkers on Cognitively Impaired Individuals Diagnosed With Dementia or Mild Cognitive Impairment: A Systematic Review and Meta-Analysis

Stigger, F. S., Zago Marcolino, M. A., Portela, K. M., & Plentz, R. D. M. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly173 · Cited by 68

The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial

Naeini, A. A., Elmadfa, I., Djazayery, A., Barekatain, M., Aghaye-Ghazvini, M. R., Djalali, M., & Feizi, A. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0628-1 · Cited by 68

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis

Wang, Q., Zhao, J., Chang, H., Liu, X., & Zhu, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.665114 · Cited by 67

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

Giovanni, G. D., Štrac, D. Š., Solé, M., Unzeta, M., Tipton, K. F., Mück‐Šeler, D., Bolea, I., Corte, L., Perković, M. N., Pivac, N., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00541 · Cited by 76

Homocysteine and its Derivatives as Possible Modulators of Neuronal and Non-Neuronal Cell Glutamate Receptors in Alzheimer's Disease

Болдырев, А. А., & Johnson, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11209 · Cited by 66

Synthesis, docking studies and antioxidant activity of some chalcone and aurone derivatives

Narsinghani, T., Sharma, M. C., & Bhargav, S. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0413-3 · Cited by 72

Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease

Subash, S., Braidy, N., Essa, M. M., Al‐Buraiki, Z., Vaishnav, R., Al‐Adawi, S., Al-Asmi, A. R., & Guillemin, G. J. (2014) · Nutrition · doi:10.1016/j.nut.2014.06.004 · Cited by 65

Homocysteine Aggravates Cortical Neural Cell Injury through Neuronal Autophagy Overactivation following Rat Cerebral Ischemia-Reperfusion

Zhao, Y., Huang, G., Chen, S., Gou, Y., Dong, Z., & Zhang, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081196 · Cited by 65

Systemic Oxidative Stress and Conversion to Dementia of Elderly Patients with Mild Cognitive Impairment

Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Bergamini, C. M., Valacchi, G., Pilotto, A., & Zuliani, G. (2014) · BioMed Research International · doi:10.1155/2014/309507 · Cited by 63

Cobalamin deficiency, hyperhomocysteinemia, and dementia

Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 57

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches

Castellani, R. J., Zhu, X., Lee, H., Smith, M. A., & Perry, G. L. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 57

Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?

Kaufman, M. J., Kanayama, G., Hudson, J. I., & Pope, H. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.014 · Cited by 56

Vitamin E and Enzymatic/Oxidative Stress-Driven Oxysterols in Amnestic Mild Cognitive Impairment Subtypes and Alzheimer's Disease

Iuliano, L., Monticolo, R., Straface, G., Spoletini, I., Gianni, W., Caltagirone, C., Bossù, P., & Spalletta, G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100780 · Cited by 52

Total antioxidant capacity is significantly lower in cocaine‐dependent and methamphetamine‐dependent patients relative to normal controls: results from a preliminary study

Walker, J., Winhusen, T. M., STORKSON, J. M., Lewis, D. F., Pariza, M. W., Somoza, E. C., & Somoza, V. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2430 · Cited by 51

Curcumin protects neuronal‐like cells against acrolein by restoring A kt and redox signaling pathways

Doggui, S., Belkacemi, A., Paka, G. D., Perrotte, M., Pi, R., & Ramassamy, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300130 · Cited by 51

Nitric Oxide Homeostasis in Neurodegenerative Diseases

Hannibal, L. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921101250 · Cited by 53

Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment

Chico, L., Simoncini, C., Gerfo, A. L., Rocchi, A., Petrozzi, L., Carlesi, C., Volpi, L., Tognoni, G., Siciliano, G., & Bonuccelli, U. (2013) · Free Radical Research · doi:10.3109/10715762.2013.804622 · Cited by 49

Oxidative Imbalance in Different Neurodegenerative Diseases with Memory Impairment

Gironi, M., Bianchi, A., Russo, A., Alberoni, M., Ceresa, L., Angelini, A., Cursano, C., Mariani, E., Nemni, R., Kullmann, C., et al. (2010) · Neurodegenerative Diseases · doi:10.1159/000319452 · Cited by 48

Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey

Aybek, H., Ercan, F., Aslan, D., & Şahiner, T. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.09.005 · Cited by 48

Beneficial effect of Toona sinensis Roemor on improving cognitive performance and brain degeneration in senescence-accelerated mice

Liao, J., Hsu, C., Wang, M.-F., Hsu, W.-M., & Chan, Y. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061823 · Cited by 47

BioAge: Toward a multi-determined, mechanistic account of cognitive aging

DeCarlo, C. A., Tuokko, H. A., Williams, D., Dixon, R. A., & MacDonald, S. W. S. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.09.003 · Cited by 50

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients

Costa, M., Horrillo, R., Ortiz, A. M., Pérez, A., Mestre, A., Ruiz, A., Boada, M., & Grancha, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180243 · Cited by 45

Understanding Redox Homeostasis and Its Role in Cancer

Dawane, J. S. (2012) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2012/4947.2654 · Cited by 44

Frailty Is Related to Subjective Cognitive Decline in Older Women without Dementia

Gifford, K. A., Bell, S. P., Liu, D., Neal, J. E., Turchan, M., Shah, A. S., & Jefferson, A. L. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15972 · Cited by 44

Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease

Castellani, R. J., Nunomura, A., Rolston, R. K., Moreira, P. I., Takeda, A., Perry, G. L., & Smith, M. A. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9050789 · Cited by 43

Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe2O3 using photocatalytic degradation technique and its echo-biomedical applications

Al-Hakkani, M. F., Gouda, G. A., Hassan, S. H. A., Saddik, M. S., El‐Mokhtar, M. A., Ibrahim, M. A., Mohamed, M. M. A., & Nagiub, A. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-14922-3 · Cited by 43

Effects of grape seed proanthocyanidin on Alzheimer's disease in vitro and in vivo

Lian, Q., Nie, Y., Zhang, X., Tan, B., Cao, H., Chen, W., Gao, W., Chen, J., Liang, Z., Lai, H., et al. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3530 · Cited by 41

Recent Progress in Autocatalytic Ceria Nanoparticles-Based Translational Research on Brain Diseases

Choi, S. W., & Kim, J. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b02243 · Cited by 39

Oral glutathione administration inhibits the oxidative stress and the inflammatory responses in AppNL−G-F/NL−G-F knock-in mice

Izumi, H., Sato, K., Kojima, K., Saito, T., Saido, T. C., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108026 · Cited by 37

NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells

Ferlazzo, N., Condello, S., Currò, M., Parisi, G., Ientile, R., & Caccamo, D. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-62 · Cited by 37

Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism

Maccioni, R. B. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3268 · Cited by 36

Total Antioxidant Status Correlates with Cognitive Impairment in Patients with Recurrent Depressive Disorder

Talarowska, M. E., Gałecki, P., Maes, M. H. J., Bobińska, K., & Kowalczyk, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0788-z · Cited by 35

Long-term administration of melatonin attenuates neuroinflammation in the aged mouse brain

Permpoonputtana, K., Tangweerasing, P., Mukda, S., Boontem, P., Nopparat, C., & Govitrapong, P. (2018) · EXCLI journal · doi:10.17179/excli2017-654 · Cited by 35

Homocysteine and electroencephalographic rhythms in Alzheimer disease: A multicentric study

Babiloni, C., Bosco, P., Ghidoni, R., Percio, C. D., Squitti, R., Binetti, G. G., Benussi, L., Ferri, R., Frisoni, G. B., Lanuzza, B., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.065 · Cited by 35

Chemical characterization and therapeutic properties ofAchillea biebersteiniileaf aqueous extract synthesized copper nanoparticles against methamphetamine‐induced cell death in PC12: A study in the nanotechnology and neurology fields

Wang, G., Ahmeda, A. F., Malek, Z., Mansooridara, S., Zangeneh, A., & Zangeneh, M. M. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.5488 · Cited by 34

Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease

Arıkanoğlu, A., Akıl, E., Varol, S., Yavuz, Y., Yüksel, H., Çevik, M. U., Palanci, Y., & Unan, F. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1346-4 · Cited by 34

In Vitro Antioxidant Properties of Dichloromethanolic Leaf Extract of Gnidia glauca (Fresen) as a Promising Antiobesity Drug

Makori, W. A., Kibiti, C. M., Njagi, J. M., & Ngugi, M. P. (2019) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x19883258 · Cited by 40

Hydrogen ameliorates chronic intermittent hypoxia-induced neurocognitive impairment via inhibiting oxidative stress

Li, W., Yang, S., Yu, F., Zhao, Y., Sun, Z., An, J., & Ji, E. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.012 · Cited by 32

Homocysteine, trace elements and oxidant/antioxidant status in mild cognitively impaired elderly persons: a cross-sectional study

Negahdar, H., Hosseini, S. R., Parsian, H., Kheirkhah, F., Mosapour, A., Khafri, S., & Haghighi, A. H. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0043 · Cited by 17

The Study of Homocysteine and Its Relationship with Oxidative Stress Biomarkers in Alzheimer’s Disease

Ghodake, M. S. R., Suryakar, A. N., Kulhalli, P. M., & Shaikh, A. K. (2016) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v3i8.04 · Cited by 1

Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease

Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15110 · Cited by 157

Management of apolipoprotein D and klotho levels, redox pattern and oxidative damages in plasma from MCI and Alzheimer′s Disease patients

Perrotte, M., Page, A. Y. L., Camponova, P., Rassart, É., Fülöp, T., & Ramassamy, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.188

Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378